Orchid Pharma Ltd.

View in App
513.00 -2.00 ▼-0.4%

22 September 2023, 04:01:00 PM
Volume: 1,324

Company Profile

View details >>
Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.orchidpharma.com
Market Cap 2,601.89 Cr.
Enterprise Value(EV) 2,902.61 Cr. 2023-03
Financial Indicators
Earnings per share (EPS) 13.95 Trailing Twelve Months Ending 2023-06
Price-Earning Ratio (PE) 36.78 Trailing Twelve Months Ending 2023-06
Industry PE 37.50 Trailing Twelve Months Ending 2023-06
Book Value / Share 216.77 Trailing Twelve Months Ending 2023-06
Price to Book Value 2.37 Calculated using Price: 513.00
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 5.07 Cr. 50,719,105 Shares
FaceValue 10
About Orchid Pharma Ltd.
Orchid Chemicals & Pharmaceuticals (Orchid) is pharmaceutical company engaged in development and manufacture of active pharmaceutical ingredients (APIs) and finished dosage forms. It is also engaged in research of new drugs. The company was Incorporated in the year 1992 as a 100% export-oriented unit (EOU).

Orchid Pharma Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Orchid Pharma Ltd. Performance

View details >>
1 Day
-0.39%
1 Week
-3.33%
1 Month
-11.51%
3 Month
+13.48%
6 Month
+29.81%
1 Year
+51.39%
2 Year
+23.57%
5 Year
+7488.76%
10 Year
+1032.45%

Orchid Pharma Ltd. Fundamental Ratios

View details >>
9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) -55.58 -147.51 -423.17 -13.43 -8.75 8.27
Return on Capital Employed (%) 4.17 -0.06 -6.93 -3.46 3.08 -6.47 -3.53 -2.32 9.11
Return on Assets (%) -4.53 -7.05 -13.59 -10.88 2.24 -5.78 -7.06 -4.85 4.73

Orchid Pharma Ltd. Balance Sheet

View details >>
Particulars 10 years 2013-09 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Shh. Funds 380 329 49 -388 -792 -704 766 653 647 689
Non Curr. Liab. 1,064 2,609 2,475 2,205 1,905 1,436 519 442 222 165
Curr. Liab. 3,206 1,123 1,338 1,541 2,013 2,346 175 142 241 372
Minority Int. 1
Equity & Liab. 4,651 4,061 3,862 3,358 3,125 3,077 1,460 1,237 1,111 1,225
Non Curr. Assets 3,550 2,783 2,611 2,479 2,446 2,310 891 687 713 724
Curr. Assets 1,101 1,278 1,251 879 679 767 569 550 384 501
Misc. Exp. not W/O
Total Assets 4,651 4,061 3,862 3,358 3,125 3,077 1,460 1,237 1,111 1,225

Orchid Pharma Ltd. Profit and Loss

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-06 Rs. Cr. TTM
Net Sales 1,747 873 797 683 600 484 450 560 666 718
Other Income 42 25 19 20 17 24 15 9 19 18
Total Income 1,789 898 816 703 617 508 465 569 685 736
Total Expenditure -1,429 -703 -709 -659 -612 -515 -399 -505 -582 -625
PBIDT 360 196 106 45 5 -7 66 64 104 112
Interest -537 -294 -331 -310 -7 -6 -52 -33 -33 -30
Depreciation -325 -145 -141 -133 -130 -118 -109 -87 -55 -41
Taxation 191 17 48 46
Exceptional Items 113 -53 -173 201 39 39
PAT -197 -279 -490 -353 69 -131 -95 -57 55 80
Minority Interest 1
Share Associate 0 -4 -2 -3
Other Related Items
Consolidated Net Profit -197 -279 -490 -353 70 -131 -117 -2 46 71
Adjusted EPS -23 -31 -55 -40 8 -32 -29 0 11 17

Orchid Pharma Ltd. Cash Flow

View details >>
Particulars 10 years 2013-09 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 168 -369 212 317 9 12 81 24 92 18
Cash Fr. Inv. -986 1,334 -1 -9 -28 45 167 67 113 -31
Cash Fr. Finan. 664 -597 -286 -366 33 0 -250 -165 -217 31
Net Change -153 367 -76 -58 15 57 -2 -74 -11 18
Cash & Cash Eqvt 23 391 315 257 35 92 90 16 4 23

Orchid Pharma Ltd. Shareholding Pattern

View details >>
9 Qtrs 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%)
Promoter 90.00 90.00 90.00 90.00 89.96 89.96 89.96 89.96 72.40
Public 10.00 10.00 10.00 10.00 10.04 10.04 10.04 10.04 27.60
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 32.68 32.68 32.68 0.00 0.00 0.00 0.00 0.00 0.00

Orchid Pharma Ltd. Announcements

View details >>
Tue, 12 Sep 2023
Announcement Under Regulation 30 Of SEBI (LODR) Regulation 2015
Announcement under regulation 30 of SEBI (LODR) Regulation 2015
Mon, 21 Aug 2023
Announcement under Regulation 30 (LODR)-Investor Presentation
Transcript of Earning Call for quarter ended June 30 2023.
Mon, 14 Aug 2023
Announcement under Regulation 30 (LODR)-Monitoring Agency Report
Monitoring Agency Report for quarter ended June 30 2023

Orchid Pharma Ltd. Technical Scans

View details >>
Fri, 22 Sep 2023
Opening at High Opening at High
Making Lower Lows for 3 days Making Lower Lows for 3 days
Close Below Last Month Low Close Below Last Month Low
Making Lower Lows for 2 Days Making Lower Lows for 2 Days
High Decrease in 1 Month High Decrease in 1 Month

Orchid Pharma Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 271,508.75 1,131.60 -1.3%
Divi's Laboratories Ltd. 98,393.27 3,708.40 -1.0%
Cipla Ltd. 95,796.29 1,184.35 -1.9%
Dr. Reddy's Laboratories Ltd. 92,004.31 5,516.35 -2.7%
Apollo Hospitals Enterprise Ltd. 71,703.97 5,003.05 -0.3%
Mankind Pharma Ltd. 70,167.07 1,751.60 +0.7%
Torrent Pharmaceuticals Ltd. 62,653.02 1,853.55 -1.1%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-06 32.19 1,131.60 -1.3%
Divi's Laboratories Ltd. Consolidated 2023-06 66.64 3,708.40 -1.0%
Cipla Ltd. Consolidated 2023-06 30.73 1,184.35 -1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-06 19.48 5,516.35 -2.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-06 107.60 5,003.05 -0.3%
Mankind Pharma Ltd. Consolidated 2023-03 54.74 1,751.60 +0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-06 49.79 1,853.55 -1.1%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-06 4.68 1,131.60 -1.3%
Divi's Laboratories Ltd. Consolidated 2023-06 7.50 3,708.40 -1.0%
Cipla Ltd. Consolidated 2023-06 3.93 1,184.35 -1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-06 3.75 5,516.35 -2.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-06 11.47 5,003.05 -0.3%
Mankind Pharma Ltd. Consolidated 2023-03 5.73 1,751.60 +0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-06 9.54 1,853.55 -1.1%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,131.60 -1.3%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,708.40 -1.0%
Cipla Ltd. Consolidated 2023-03 0.02 1,184.35 -1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,516.35 -2.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 5,003.05 -0.3%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 1,751.60 +0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 1,853.55 -1.1%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,131.60 -1.3%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,708.40 -1.0%
Cipla Ltd. Consolidated 2023-03 12.85 1,184.35 -1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,516.35 -2.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,003.05 -0.3%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,751.60 +0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 1,853.55 -1.1%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,131.60 -1.3%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,708.40 -1.0%
Cipla Ltd. Consolidated 2023-03 12.85 1,184.35 -1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,516.35 -2.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,003.05 -0.3%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,751.60 +0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 1,853.55 -1.1%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,131.60 -1.3%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,708.40 -1.0%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,184.35 -1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,516.35 -2.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 5,003.05 -0.3%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 1,751.60 +0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 1,853.55 -1.1%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,131.60 -1.3%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,708.40 -1.0%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,184.35 -1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,516.35 -2.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 5,003.05 -0.3%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 1,751.60 +0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 1,853.55 -1.1%

Orchid Pharma Ltd. FAQ's

What is Orchid Pharma share price?
Can I buy Orchid Pharma shares now?
What is the Market Cap of Orchid Pharma?
What are the key metrics to analyse Orchid Pharma?
What is the 52 Week High and Low of Orchid Pharma?
What is the trend of Orchid Pharma share price?